Cargando…
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer
INTRODUCTION: Patients with advanced germ cell tumors (GCT) receiving cisplatin-based chemotherapy have high rates of thromboembolic events (TEE) which can negatively affect their overall survival. While primary TEE prophylaxis during chemotherapy may prevent these events, it is unclear which patien...
Autores principales: | Meng, Xiaosong, Ahmed, Murtaza, Courtney, Kevin D., Arafat, Waddah, Ibrahim, Ibrahim, Margulis, Vitaly, Nichols, Craig, Bagrodia, Aditya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529113/ https://www.ncbi.nlm.nih.gov/pubmed/34692501 http://dx.doi.org/10.3389/fonc.2021.724682 |
Ejemplares similares
-
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
por: Schoenhals, Jonathan E., et al.
Publicado: (2021) -
Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors
por: Saidian, Ava, et al.
Publicado: (2023) -
Germ Cell Tumors: Updates on Epidemiology, Biology, and Treatment Considerations
por: Bagrodia, Aditya, et al.
Publicado: (2018) -
Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma
por: Verhage, Roy J. J., et al.
Publicado: (2011) -
Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
por: Bazarbashi, Shouki, et al.
Publicado: (2022)